CIRM Clinical Dashboard

Funding Clinical Trials

Our Agency funds clinical trials testing promising stem cell-based treatments for currently incurable diseases or disorders to help patients with unmet medical needs. For basic information about stem cell trials, visit our Clinical Trials 101 page. For a list of clinical trials that are a result of early-stage CIRM grants click here.

CIRM Clinical Dashboard

Disease Areassort ascending Investigator Organization Phase Trial Status Targeted Enrollment Detail
Peter Stock University of California, San Francisco Phase 1/2 Recruiting 8
William Sietsema Caladrius Biosciences Phase 2 Completed 113
Howard Foyt ViaCyte, Inc. Phase 1/2 Closed 19
Manasi Jaiman ViaCyte, Inc. Phase 1/2 Active, not recruiting 75
Gary Steinberg Stanford University Phase 1 Recruiting 30
Bijan Nejadnik SanBio, Inc. Phase 2 Completed 163
Francois Binette Lineage Cell Therapeutics Inc. Phase 1/2 Completed 25
Jane Lebkowski Geron Corporation Phase 1 Completed 5
  • Spina Bifida
 Diana Farmer University of California, Davis Phase 1 Recruiting 55
Pamela Contag BioEclipse Therapeutics INC. Phase 1 Recruiting 24
Dennis Slamon University of California, Los Angeles Phase 1 Completed 48
Mark Walters University of California, San Francisco Phase 1 Launching N/A
Joseph Rosenthal City of Hope, Beckman Research Institute Phase 1 Recruiting 6
Pierre Caudrelier ExCellThera Inc. Phase 1 Withdrawn N/A
David Williams Boston Children's Hospital Phase 2 Active, not recruiting 10
  • Severe Combined Immunodeficiency, Artemis deficient (ART-SCID)
 Morton Cowan University of California, San Francisco Phase 1 Recruiting 25
  • Sarcoma
 Theodore Nowicki University of California, Los Angeles Phase 1 Recruiting 12
Henry Klassen University of California, Irvine Phase 1/2 Completed 28
Henry Klassen jCyte, Inc Phase 2 Completed 84
Clive Svendsen Cedars-Sinai Medical Center Phase 1 Recruiting 16
Henry Klassen jCyte, Inc Phase 2 Completed 84
  • Pulmonary Hypertension
  • Vascular Disease
 Michael Lewis Cedars-Sinai Medical Center Phase 1/2 Active, not recruiting 26
Donald Kohn University of California, Los Angeles Phase 1 Recruiting 6
Krystof Bankiewicz Brain Neurotherapy Bio Phase 1 Recruiting 12
Nancy Lane University of California, Davis Phase 1/2 Completed 58
  • Muscle Injury
 Peter Belafsky University of California, Davis Phase 1/2 Recruiting 62
  • Multiple Myeloma
 Rajesh Belani Poseida Therapeutics, Inc. Phase 1 Closed 105
Robert Dillman Caladrius Biosciences Phase 3 Closed 4
Antoni Ribas University of California, Los Angeles Phase 1 Recruiting 12
Steven Dubinett University of California, Los Angeles Phase 1 Recruiting 24
  • Leukemia, Acute Myeloid (AML)
 Mark Chao Forty Seven Inc. Phase 1 Active, not recruiting 258
  • Leukemia, Acute Myeloid (AML)
 Colleen Delaney Nohla Therapeutics Inc Phase 2 Closed 146
  • Leukemia, Acute Myeloid (AML)
 Joseph Woodard Immune-Onc Therapeutics Phase 1 Recruiting 119
Daniel Brennan Medeor Therapeutics, Inc. Phase 3 Active, not recruiting 30
Everett Meyer Stanford University Phase 1 Recruiting 22
Jeffrey Lawson Humacyte, Inc. Phase 3 Active, not recruiting 355
Robert Lowsky Stanford University Phase 1 Active, not recruiting 15
Jeffrey Lawson Humacyte, Inc. Phase 3 Recruiting 240
  • IPEX Syndrome
 Rosa Bacchetta Stanford University Phase 1 Recruiting 36
  • Immune Disease
  • Pediatrics
  • X-linked Chronic Granulomatous Disease
 Donald Kohn University of California, Los Angeles Phase 1/2 Active, not recruiting 16
Stephen Gottschalk St. Jude Children's Research Hospital Phase 1/2 Recruiting 28
  • Immune Disease
  • Leukocyte Adhesion Deficiency
 Kinnari Patel Rocket Pharmaceuticals, Inc. Phase 1/2 Active, not recruiting 9
Judith Shizuru Stanford University Phase 1/2 Recruiting 40
Vicki Wheelock University of California, Davis Phase 1/2 Completed 29
William Kennedy Excision BioTherapeutics Phase 1 Recruiting 9
Geoff Symonds Calimmune, Inc. Phase 1/2 Completed 13
John Zaia City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 12
Steven Deeks University of California, San Francisco Phase 1/2 Launching N/A
Mehrdad Abedi University of California, Davis Phase 1/2 Recruiting 18
Joseph Wu Stanford University Phase 1 Recruiting 18
Rachel Smith Capricor, Inc Phase 2 Closed 156
Linda Marban Capricor, Inc Phase 2 Completed 25
Donald Kohn University of California, Los Angeles Phase 2 Completed 10
  • Epilepsy
 Cory Nicholas Neurona Therapeutics Phase 1 Recruiting 40
Stephanie Cherqui University of California, San Diego Phase 1/2 Recruiting 6
John Zaia City of Hope, Beckman Research Institute Phase 1 Launching N/A
  • COVID-19
 Michael Matthay University of California, San Francisco Phase 2 Recruiting 120
William van der Touw Celularity Inc Phase 1/2 Active, not recruiting 86
  • Corneal Damage
 Sophie Deng University of California, Los Angeles Phase 1 Recruiting 20
Mark Chao Forty Seven Inc. Phase 1/2 Completed 78
Crystal Mackall Stanford University Phase 1 Recruiting 54
Jana Portnow City of Hope, Beckman Research Institute Phase 1 Launching N/A
Saul Priceman City of Hope, Beckman Research Institute Phase 1 Recruiting 39
Anthony Gringeri ImmunoCellular Therapeutics Phase 3 Suspended 414
Leo Wang City of Hope, Beckman Research Institute Phase 1 Recruiting 18
Christine Brown City of Hope, Beckman Research Institute Phase 1 Active, not recruiting 82
Gayatri Rao Rocket Pharmaceuticals, Inc. Phase 1 Closed 1
Michael Pulsipher Children's Hospital of Los Angeles Phase 1/2 Active, not recruiting 60
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 42
Thomas Kipps University of California, San Diego Phase 1 Completed 26
Irving Weissman Stanford University Phase 1 Completed 88
Edward Kavalerchik Angiocrine Bioscience, Inc. Phase 1 Completed 10
  • Bladder or Urinary Tract Disorder
 James Yoo Wake Forest University Health Sciences Phase 1 Not yet recruiting 10
  • Beta Thalassemia
 Bettina Cockroft Sangamo BioSciences, Inc. Phase 1/2 Active, not recruiting 6
  • B cell cancers
  • Leukemia
  • Leukemia, Acute Myeloid (AML)
 Maria Grazia Roncarolo Stanford University Phase 1 Recruiting 22
David Miklos Stanford University Phase 1 Recruiting 60
Thomas Kipps University of California, San Diego Phase 1/2 Recruiting 138
Kristen Johnson Calibr Phase 1 Completed 60
Clive Svendsen Cedars-Sinai Medical Center Phase 1/2 Completed 18
Ralph Kern BrainStorm Cell Therapeutics Phase 3 Completed 263
Clive Svendsen Cedars-Sinai Medical Center Phase 1 Launching N/A
  • Alpha Thalassemia Major
 Tippi MacKenzie University of California, San Francisco Phase 1 Enrolling by invitation 10
Mark Humayun University of Southern California Phase 1 Active, not recruiting 16
Icon for XLSX export